NutFinForce: The Impact of Digitally Delivered Lifestyle Performance Medicine Intervention on Defense Performance in Finland
Launched by UNIVERSITY OF HELSINKI · Jan 23, 2025
Trial Information
Current as of July 01, 2025
Not yet recruiting
Keywords
ClinConnect Summary
The NutFinForce trial is studying how a special digital program can help improve performance for individuals in military service in Finland. This program focuses on lifestyle changes and aims to support soldiers in becoming their best selves during their training. It's important to note that this trial is not currently recruiting participants, but when it does, it will involve individuals aged between 65 and 74 years old, as well as those who are 10957 years old (a likely typographical error, as this age seems unrealistic). All genders are welcome to participate.
To be eligible for this trial, participants must be involved with the Finnish Defense Forces and must not have any conflicts with attending military service. If selected, participants will engage in the program without the Defense Forces knowing whether they are attending or not, ensuring their service terms remain unaffected. Overall, this trial aims to provide valuable insights into how digital tools can support military personnel, enhancing their performance and well-being.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • The participants for the intervention are recruited along with the invitation process of the Finnish Defense Forces in such a way that it does not interfere with the actual goal itself: attending the military service.
- • Attendance for the intervention, suspension of the intervention or not attending is not known by the Defense Forces and does not influence terms of service
- Exclusion Criteria:
- • Not attending the military service
About University Of Helsinki
The University of Helsinki, a prestigious institution in Finland, is dedicated to advancing health sciences through innovative research and clinical trials. With a strong emphasis on interdisciplinary collaboration, the university engages in cutting-edge studies that aim to improve patient outcomes and contribute to the global knowledge base in medicine. Its commitment to ethical standards and rigorous methodology ensures the integrity and reliability of its clinical research initiatives, making it a key player in the development of novel therapeutic strategies and healthcare solutions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Helsinki, , Finland
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported